99 related articles for article (PubMed ID: 27046798)
1. High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study.
D'Angelo A; Valsecchi L;
Thromb Res; 2016 Apr; 140():7-13. PubMed ID: 27046798
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia.
Paidas MJ; Tita ATN; Macones GA; Saade GA; Ehrenkranz RA; Triche EW; Streisand JB; Lam GK; Magann EF; Lewis DF; Dombrowski MP; Werner EF; Branch DW; Habli MA; Grotegut CA; Silver RM; Longo SA; Amon E; Cleary KL; How HY; Novotny SR; Grobman WA; Whiteman VE; Wing DA; Scifres CM; Sibai BM
Am J Obstet Gynecol; 2020 Nov; 223(5):739.e1-739.e13. PubMed ID: 32780999
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group.
Maki M; Kobayashi T; Terao T; Ikenoue T; Satoh K; Nakabayashi M; Sagara Y; Kajiwara Y; Urata M
Thromb Haemost; 2000 Oct; 84(4):583-90. PubMed ID: 11057854
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation; a randomized, double-blind, placebo-controlled trial.
Sameshima H; Kodama Y; Ikenoue T; Kajiwara Y
J Obstet Gynaecol Res; 2008 Feb; 34(1):34-9. PubMed ID: 18226126
[TBL] [Abstract][Full Text] [Related]
5. A randomized phase 3 trial evaluating antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia (KOUNO-TORI study): Study protocol.
Saito S; Takagi K; Moriya J; Kobayashi T; Kanayama N; Sameshima H; Morikawa M; Sago H; Adachi T; Ohkuchi A; Takeda S; Masuyama H; Seki H
Contemp Clin Trials; 2021 Aug; 107():106490. PubMed ID: 34174463
[TBL] [Abstract][Full Text] [Related]
6. Exploring the role of antithrombin replacement for the treatment of preeclampsia: a prospective randomized evaluation of the safety and efficacy of recombinant antithrombin in very preterm preeclampsia (PRESERVE-1).
Paidas MJ; Sibai BM; Triche EW; Frieling J; Lowry S;
Am J Reprod Immunol; 2013 Jun; 69(6):539-44. PubMed ID: 23444920
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
8. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
Ayala DE; Ucieda R; Hermida RC
Chronobiol Int; 2013 Mar; 30(1-2):260-79. PubMed ID: 23004922
[TBL] [Abstract][Full Text] [Related]
9. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study.
Kobayashi T; Terao T; Ikenoue T; Sameshima H; Nakabayashi M; Kajiwara Y; Maki M;
Semin Thromb Hemost; 2003 Dec; 29(6):645-52. PubMed ID: 14719181
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of AT in pre-eclampsia: a case-control prospective trial.
Paternoster DM; Fantinato S; Manganelli F; Milani M; Nicolini U; Girolami A
Thromb Haemost; 2004 Feb; 91(2):283-9. PubMed ID: 14961155
[TBL] [Abstract][Full Text] [Related]
12. Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol.
Cluver CA; Walker SP; Mol BW; Theron GB; Hall DR; Hiscock R; Hannan N; Tong S
BMJ Open; 2015 Oct; 5(10):e008211. PubMed ID: 26510725
[TBL] [Abstract][Full Text] [Related]
13. Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status.
Rumiris D; Purwosunu Y; Wibowo N; Farina A; Sekizawa A
Hypertens Pregnancy; 2006; 25(3):241-53. PubMed ID: 17065044
[TBL] [Abstract][Full Text] [Related]
14. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.
Combs CA; Garite TJ; Maurel K; Abril D; Das A; Clewell W; Heyborne K; How H; Huang W; Lewis D; Lu G; Miller H; Nageotte M; Porreco R; Sheikh A; Tran L;
Am J Obstet Gynecol; 2015 Sep; 213(3):364.e1-12. PubMed ID: 25979614
[TBL] [Abstract][Full Text] [Related]
15. Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.
Lam GK; Hopoate-Sitake M; Adair CD; Buckalew VM; Johnson DD; Lewis DF; Robinson CJ; Saade GR; Graves SW
Am J Obstet Gynecol; 2013 Aug; 209(2):119.e1-6. PubMed ID: 23583219
[TBL] [Abstract][Full Text] [Related]
16. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women.
Villar J; Abdel-Aleem H; Merialdi M; Mathai M; Ali MM; Zavaleta N; Purwar M; Hofmeyr J; Nguyen TN; Campódonico L; Landoulsi S; Carroli G; Lindheimer M;
Am J Obstet Gynecol; 2006 Mar; 194(3):639-49. PubMed ID: 16522392
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.
Byrnes JW; Swearingen CJ; Prodhan P; Fiser R; Dyamenahalli U
ASAIO J; 2014; 60(1):57-62. PubMed ID: 24296776
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia.
Samangaya RA; Mires G; Shennan A; Skillern L; Howe D; McLeod A; Baker PN
Hypertens Pregnancy; 2009 Aug; 28(4):369-82. PubMed ID: 19843000
[TBL] [Abstract][Full Text] [Related]
19. Magnesium supplementation and preeclampsia in low-income pregnant women - a randomized double-blind clinical trial.
de Araújo CAL; de Sousa Oliveira L; de Gusmão IMB; Guimarães A; Ribeiro M; Alves JGB
BMC Pregnancy Childbirth; 2020 Apr; 20(1):208. PubMed ID: 32272914
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial.
Groom KM; McCowan LM; Mackay LK; Lee AC; Said JM; Kane SC; Walker SP; van Mens TE; Hannan NJ; Tong S; Chamley LW; Stone PR; McLintock C;
Am J Obstet Gynecol; 2017 Mar; 216(3):296.e1-296.e14. PubMed ID: 28153659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
